Insulin-stimulated signaling pathways regulate insulin receptor substrate (IRS) activity in various tissues, including muscle and pancreatic beta cells, and have been identified as a pathogenic factor in diabetes onset (Yiannakouris, 202). The gene discussed is INS; the disease is diabetes mellitus.